Market Place
Sourcing Support
Dr. Sam Barrell CBE appointed as CEO of LifeArc
19 Apr 2024 //
GLOBENEWSWIRE
LifeArc makes multi-million pound investment
31 Jan 2024 //
GLOBENEWSWIRE
LifeArc Ventures - six new investments, portfolio progress
25 Jan 2024 //
PR NEWSWIRE
LifeArc announces £5 million drug repurposing programme for motor neuron disease
06 Dec 2023 //
GLOBENEWSWIRE
LifeArc- research project trialling test to help fight against threat of antimicrobial resistance
30 Nov 2023 //
GLOBENEWSWIRE
Multi-Million Pound Boost For Research Projects Aimed At Developing New Tests
13 Nov 2023 //
GLOBENEWSWIRE
New documentary highlights pioneering scientific research into new targets
10 Nov 2023 //
GLOBENEWSWIRE
New documentary highlights pioneering scientific research into new targets
09 Nov 2023 //
GLOBENEWSWIRE
LifeArc welcomes Stéphane Maikovsky as Interim CEO
02 Oct 2023 //
GLOBENEWSWIRE
New UK partnership and research fund aims to tackle infectious diseases
10 Aug 2023 //
GLOBENEWSWIRE
LifeArc and DEBRA Austria launch £2.5 million funding call
10 Jul 2023 //
GLOBENEWSWIRE
Groundbreaking new £100m LifeArc programme aims to improve a rare disease
06 Jul 2023 //
GLOBENEWSWIRE
LifeArc strengthens Board of Trustees with new appointments
27 Jun 2023 //
GLOBENEWSWIRE
LifeArc Ventures invests in Maxion Therapeutics to drive antibody development
15 Feb 2023 //
PR NEWSWIRE
LifeArc commits £10m to fund repurposed chronic respiratory infection therapies
24 Nov 2022 //
PHARMAPHORUM
New toolkit launched to help navigate medicines repurposing
10 Oct 2022 //
PHARMIWEB
LifeArc and MRC launch toolkit to navigate medicines repurposing
10 Oct 2022 //
PHARMATIMES
LifeArc portfolio company Ducentis acquired by Arcutis Bio for $400 million
08 Sep 2022 //
PRNEWSWIRE
LifeArc co-founded company RQ Bio signs licensing agreement with AstraZeneca
16 May 2022 //
PRNEWSWIRE
Metrion Biosciences and LifeArc Extend Ion Channel Drug Discovery Collaboration
03 Dec 2019 //
BUSINESS WIRE
LifeArc makes $30M Kymab investment to access antibody tech
24 Jun 2019 //
FIERCE BIOTECH
Charity LifeArc sells rights to Keytruda for more than $1bn
20 May 2019 //
PHARMACEITICAL-TECHNOLOGY
LifeArc & GVK BIO Celebrate a Decade of Partnership,Transforming Research
15 May 2019 //
BUSINESSWIRE
LifeArc inks pain medicine development deal with Uni of Kent
24 Apr 2019 //
PHARMA TIMES
LifeArc licenses discovery programme to Daiichi Sankyo
17 Apr 2019 //
PHARMA TIMES
Cancer immunotherapy alliance formed by CR UK, Lifearc and Ono Pharma Form
28 Mar 2019 //
PHARMA TIMES
UK research charity LifeArc appoints experienced leader Melanie Lee as new CEO
05 Sep 2018 //
PHARMA FILE
LifeArc and AUTM partner for tech transfer training
30 Aug 2017 //
PHARMA TIMES
LifeArc teams up with UK defence lab and Canada’s CDRD
29 Jun 2017 //
PHARMA TIMES
